Myeloablative Conditioning With Intravenous Busulphan in a Single Daily Dose and Fludarabine (BUF) for HLA-identical Sibling Allogeneic HSCT in Myeloid Malignancies
J. De la Serna, A. Bermudez, J. Sanz, D. Caballero, R. De la Cámara, C. Vallejo, D. Serrano, J.M. Moraleda, L. Benlloch, G. SanzVolume:
17
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.bbmt.2010.12.436
File:
PDF, 68 KB
english, 2011